The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model

OBJECTIVES: Cholestasis refers to a reduction in bile flow from the liver into the biliary system. Ursodeoxycholic acid (UDCA) is commonly used for the treatment of hepatic cholestasis. This study aimed to explore the role of UDCA in the treatment and prevention of lipopolysaccharide (LPS)-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ainosah, Randa H., Hagras, Magda M., Alharthi, Sameer E., Saadah, Omar I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479157/
https://www.ncbi.nlm.nih.gov/pubmed/32982635
http://dx.doi.org/10.1016/j.jtumed.2020.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479157/
https://www.ncbi.nlm.nih.gov/pubmed/32982635
http://dx.doi.org/10.1016/j.jtumed.2020.04.007

Ejemplares similares